Using transposon mutagenesis, a BCG library, was screened for differences in colony formation. One clone, BCG TN18D9, was identified which demonstrates a unique phenotypic growth pattern in culture. The gene was cloned and sequenced and shown to be a member of a Glycine-rich family of proteins recently identified from the sequencing of M. tuberculosis H37Rv. We have made a His-tagged construct and used Nickel-column chromatography to purify the 18D9 protein from an E. coli expression system. This protein is being used for structural and functional studies. A DNA-vaccine construct has also been made and mice have been immunized to study the immune response to this protein and for its ability to protect against challenge with virulent M. tb organisms. Further studies will focus on characterization of this novel antigen as a mycobacterial virulence factor.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BJ006017-01
Application #
6101158
Study Section
Special Emphasis Panel (LM)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost